Two 2024 systematic reviews evaluated the effect of routine iron supplementation compared to placebo or no treatment on maternal and birth outcomes (175, 176)
An increasing number of problems are reported in relation to carnitine metabolism in preterm infants not receiving an exogenous source of carnitine
Science gave us peptides with extraordinary therapeutic potential
Proper storage, as covered in our guides on compounded tirzepatide storage duration and refrigeration requirements , protects potency and safety
Lifestyle interventions like regular exercise, stress reduction through mindfulness, and a balanced diet rich in aphrodisiac nutrients (e.g., zinc, omega-3s) can help by boosting blood flow and hormone balance, but after 40, these may not suffice as baseline melanocortin efficiency drops by 30-50% in some women, leading to persistent HSDD.[1][2] This is where PT-141 excels: as an MC4R agonist, it directly reactivates arousal pathways to mimic natural desire, enhancing libido and response without daily commitmentclinical trials show 51% of women experienced improved desire versus 21% on placebo.[1] Preclinical and human studies demonstrate it reverses HSDD by increasing dopamine in the hypothalamus, offering a targeted boost for those with hormonal or neurological barriers.[2] Pairing it with HRT can sustain these effects longer, as estrogen replenishes vaginal tissues that PT-141 stimulates for better lubrication and comfortscientific evidence shows this combination addresses both neurological and hormonal roots, yielding better outcomes than either alone, with up to 60% reporting reduced pain and heightened satisfaction.[3][9] For a scientific lens, HRT modulates estrogen receptors to improve GSM, while PT-141's cAMP pathway amplifies neural signaling, creating synergy that enhances overall function
